Drug recall
Indomethacin extended release capsules, USP 75mg, 60 count bottles, NDC#62584-312-60.
FDA recall event 32206 · Class II · Amerisource Health Services
Key facts
| Event ID | 32206 |
|---|---|
| Recall numbers | D-371-5, D-372-5, D-373-5, D-374-5 |
| Recalling firm | Amerisource Health Services |
| Product type | Drugs |
| Products | Indomethacin extended release capsules, USP 75mg, 60 count bottles, NDC#62584-312-60., Lithium Carbonate Capsules, USP, 300 mg, NDC #68084-042-01, packaged in 100 count box ( each box containing 10 blister cards x 10 tablets per card)., Propoxyphene Napsylate and Acetaminophen tablets USP 100 mg/650mg tablets, packaged 450 count box (packaged as 15 cards containing 30 tablets per card), NDC #62584-919-85., Propoxyphene Napsylate and Acetaminophen tablets, USP 100 mg/650mg tablets, packaged in 100 count box ( each box containing 10 blister cards x 10 tablets per card), NDC #62584-919-01. |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Recalled at the request of the manufacturer, Able Laboratories, because of serious concerns that the products were not produced according to quality assurnace standards. |
| Initiation date | May 31, 2005 |
| Termination date | Nov 13, 2008 |
| City | Columbus |
| State | OH |
| Country | United States |
| FEI number | 3000209995 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports